logo/base Created with Sketch.
de
chevron Contact
Deutsch version chevron
Region wechseln
chevron Zurück
Webinar | 09.04.2021

Fettleibigkeit und Fettlebererkrankung: Zwillingsepidemien

clock 05/20/2020

Präsentation nur auf Englisch

 

Nationwide, more than half of adults with non-alcoholic fatty liver disease (NAFLD) are obese, and more than 30% are overweight.
In this webinar, we welcome guest speaker Dr. Caroline Apovian, Director of Nutrition and Weight Management at Boston Medical Center, to present new information on the relationship between obesity and non-alcoholic fatty liver disease.

Learning Objectives

  • Understanding the treacherous trifecta of obesity, diabetes and NAFLD.
  •  Review new recommendations for evaluations of liver health in TD2M patients from the American Diabetes Association. 
  •  Overview of NAFLD-NASH disease progression and prevalence.
  •  Review current diagnostic tools and combination score.

 

About Dr. Apovian

Dr. Caroline M. Apovian, MD, FACP, FTOS, DABOM is Professor of Medicine and Pediatrics in the Section of Endocrinology, Diabetes, Nutrition and Weight Management at Boston University School of Medicine, Boston, MA, USA. She is also Director of the Nutrition and Weight Management Center and the Fellowship Program in Obesity Medicine and Nutrition at Boston Medical Center (BMC). For over thirty years, Dr. Apovian has held a position at the forefront of the obesity and nutrition fields. One of the world’s premier weight loss experts, she has distinguished herself as a leading researcher, healthcare provider, teacher, and New York Times bestselling author.

 

Speaker

Caroline M. Apovian
MD, FACP, FTOS, DABOM is Professor of Medicine and Pediatrics in the Section of Endocrinology, Diabetes, Nutrition and Weight Management at Boston University School of Medicine, Boston, MA, USA
chevron Watch replay